Skip to main content
SpringerLink
Log in

Humane Papillomvirusinfektionen im Kopf-Hals-Bereich im öffentlichen Bewusstsein

Mahnung zu Präzision in Diagnostik und Öffentlichkeitsarbeit

Public awareness of human papilloma virus infection in the head and neck area

An appeal for precision in diagnostics and for public health awareness

  • Übersichten
  • Published:
HNO Aims and scope Submit manuscript

Zusammenfassung

Humane Papillomviren (HPV) nehmen auch in der Karzinogenese von Kopf-Hals-Karzinomen eine bedeutende Rolle ein. Karzinome dieser Ätiologie können als eigene Tumorentität verstanden werden, wobei Patienten mit HPV-positiven Karzinomen in Abhängigkeit von der durchgeführten Therapie längere Überlebenszeiten zeigen. Dennoch ist das öffentliche Bewusstsein in Deutschland für die Thematik überraschend gering; Impfempfehlungen zur Prophylaxe HPV-bedingter Erkrankungen berücksichtigen in Deutschland ausschließlich Erkrankungen des weiblichen Genitaltrakts. Wissenschaftliche Erkenntnisse vor allem aus den USA werden häufig als beispielhaft auch für Populationen anderer Länder angeführt, sodass der Erfassung eigener (sozio)epidemiologischer Daten, die ggf. eine HPV-Vakzinierung auch von Jungen rechtfertigen würden, bisher ein minderer Stellenwert zugeordnet wird. Der Beitrag setzt sich kritisch mit dem wissenschaftlichen und öffentlichen Bewusstsein zur Thematik auseinander und hat zum Ziel, Präzision in Diagnostik und Öffentlichkeitsarbeit zu fordern, um die Voraussetzung zu schaffen, unsere Bevölkerung mit HPV-bedingten Erkrankungen optimal zu behandeln oder sie gar davor zu schützen.

Abstract

Infection with human papilloma virus (HPV) has been associated with head and neck carcinomas. Experts in HPV-positive carcinomas consider these carcinomas to be a new entity, because it has been shown that treatment outcome is excellent with significantly longer overall survival dependent of therapy. Despite this, in Germany public awareness of this development is rather low. A strategy for prophylactic vaccination against HPV-associated diseases has been available since 2007 but only to reduce the incidence of cervical cancer for girls between 12 and 17 years of age. There is an ongoing debate in Germany about the efficacy and safety of HPV vaccination. The results of epidemiological research in the USA which show that vaccination in young males is valuable are still not accepted in Germany. This article discusses the scientific and public awareness regarding this topic and calls for precision in diagnostics and public health awareness in order to establish a fertile ground for prevention and optimal treatment of HPV-associated diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. zur Hausen H (2009) Papillomaviruses in the causation of human cancers—a brief historical account. Virology 384(2):260–265

    Article  Google Scholar 

  2. Muller M, Gissmann L (2007) A long way: history of the prophylactic papillomavirus vaccine. Dis Markers 23(4):331–336

    PubMed  Google Scholar 

  3. Lehtinen M, Paavonen J, Wheeler CM et al (2012) Overall efficacy of HPV-16/18 AS 04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol 13(1):89–99

    Article  PubMed  CAS  Google Scholar 

  4. Mahnke CG, Werner JA, Frohlich O et al (1998) Clinical and molecular biology studies of respiratory papillomatosis. Laryngorhinootologie 77(3):157–164

    Article  PubMed  CAS  Google Scholar 

  5. Pawlita M, Gissmann L (2009) Recurrent respiratory papillomatosis: indication for HPV vaccination? Dtsch Med Wochenschr 134(Suppl 2):100–102

    Article  Google Scholar 

  6. Chaturvedi AK, Engels EA, Pfeiffer RM et al (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29(32):4294–4301

    Article  PubMed  Google Scholar 

  7. Lowy DR, Schiller JT (2012) Reducing HPV-associated cancer globally. Cancer Prev Res (Phila) 5(1):18–23

    Article  Google Scholar 

  8. Daley EM, Marhefka SL, Buhi ER et al (2010) Human papillomavirus vaccine intentions among men participating in a human papillomavirus natural history study versus a comparison sample. Sex Transm Dis 37(10):644–652

    PubMed  Google Scholar 

  9. Hoffmann M, Ihloff AS, Gorogh T et al (2010) p16(INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer. Int J Cancer 127(7):1595–1602

    Article  PubMed  CAS  Google Scholar 

  10. Hoffmann M, Gorogh T, Gottschlich S et al (2005) Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients. Cancer Lett 218(2):199–206

    Article  PubMed  CAS  Google Scholar 

  11. Tribius S, Ihloff AS, Rieckmann T et al (2011) Impact of HPV status on treatment of squamous cell cancer of the oropharynx: what we know and what we need to know. Cancer Lett 304(2):71–79

    Article  PubMed  CAS  Google Scholar 

  12. Straetmans JM, Olthof N, Mooren JJ et al (2009) Human papillomavirus reduces the prognostic value of nodal involvement in tonsillar squamous cell carcinomas. Laryngoscope 119(10):1951–1957

    Article  PubMed  Google Scholar 

  13. Nasman A, Attner P, Hammarstedt L et al (2009) Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 125(2):362–366

    Article  PubMed  Google Scholar 

  14. Schache AG, Liloglou T, Risk JM et al (2011) Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination. Clin Cancer Res 17(19):6262–6271

    Article  PubMed  CAS  Google Scholar 

  15. Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14(2):467–475

    Article  PubMed  CAS  Google Scholar 

  16. Termine N, Panzarella V, Falaschini S et al (2008) HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988–2007). Ann Oncol 19(10):1681–1690

    Article  PubMed  CAS  Google Scholar 

  17. Ang KK, Harris J, Wheeler R et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363(1):24–35

    Article  PubMed  CAS  Google Scholar 

  18. D’Souza G, Kreimer AR, Viscidi R et al (2007) Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356(19):1944–1956

    Article  Google Scholar 

  19. Nyitray AG, Carvalho da Silva RJ, Baggio ML et al (2011) Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: the HPV in men study. J Infect Dis 204(11):1711–1722

    Article  PubMed  Google Scholar 

  20. Dietz CA, Nyberg CR (2011) Genital, oral, and anal human papillomavirus infection in men who have sex with men. J Am Osteopath Assoc 111(3 Suppl 2):19–25

    Google Scholar 

  21. Kreimer AR, Villa A, Nyitray AG et al (2011) The epidemiology of oral HPV infection among a multinational sample of healthy men. Cancer Epidemiol Biomarkers Prev 20(1):172–182

    Article  PubMed  Google Scholar 

  22. International Papillomavirus Society (o J) Homepage. http://www.ipvsoc.org

  23. Hoffmann M, Tribius S, Quabius ES et al (2012) HPV DNA, E6*I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer – how valid is p16INK4A as surrogate marker? Cancer Lett 323(1): 88–96

    Article  PubMed  CAS  Google Scholar 

Download references

Interesssenkonflikt

Der korrespondierende Autor gibt für sich und seine Koautoren an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Klinik für Hals-, Nasen-, Ohrenheilkunde, Kopf- und Halschirurgie, Christian-Albrechts-Universität zu Kiel, Arnold-Heller-Str. 3, Haus 27, 24105, Kiel, Deutschland

    M. Hoffmann

  2. Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck, Deutschland

    A.S. Hoffmann

  3. Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Universitätsklinik Hamburg-Eppendorf, Hamburg, Deutschland

    S. Tribius

Authors
  1. M. Hoffmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A.S. Hoffmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Tribius
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Hoffmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoffmann, M., Hoffmann, A. & Tribius, S. Humane Papillomvirusinfektionen im Kopf-Hals-Bereich im öffentlichen Bewusstsein. HNO 60, 968–973 (2012). https://doi.org/10.1007/s00106-012-2552-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00106-012-2552-8

Schlüsselwörter

Keywords

Search

Navigation